With the newly completed OT-101 and IL-2 Phase 1 trial, Oncotelic is poised to begin further combination trials to determine the added efficacy of OT-101, IL-2, and CKIs in solid tumors such as lung ...

Building upon its already impressive obesity drug portfolio, Novo Nordisk A/S has licensed a triple agonist of the receptors for GLP-1, GIP and glucagon from United Biotechnology Co. Ltd. China-based ...

Cuomo’s Start-Up New York program created a network of tax-free zones tied to colleges and universities. Starting in 2014, it ...

U.S. Army Garrison Humphreys Soldiers conducted 48-hour field operations as part of the Freedom Shield 25, here, March ...

On a 300-acre farm in an undisclosed location in rural Wisconsin, surrounded by fields dotted with big red barns and bordered ...

A high throughput screen of >30,000 diverse repressor domains from across the tree of life identifies repressor domains with unique structures that underpin enhanced epigenetic effector domain ...

Manchester United drew 1-1 with Real Sociedad in the Europa League. Here are the players who surprised — and the ones who disappointed. Due to Manchester United's struggles in the Premier League ...

LGT Fund Management Co Ltd. acquired a new stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and ...

TORONTO, March 03, 2025 (GLOBE NEWSWIRE) — TORONTO, March 3, 2025 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV ...

HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $ ...

United Therapeutics stock opened at $319.96 on Thursday. United Therapeutics has a 12-month low of $221.53 and a 12-month high of $417.82. The company has a market capitalization of $14.28 billion ...